Skip to main content
UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
300.44
+22.33 (8.03%)
At close: Mar 9, 2026

UCB SA Revenue

In the year 2025, UCB SA had annual revenue of 7.74B EUR with 25.83% growth. UCB SA had revenue of 4.25B in the half year ending December 31, 2025, with 59.74% growth.

Revenue
7.74B EUR
Revenue Growth
+25.83%
P/S Ratio
6.10
Revenue / Employee
792.73K EUR
Employees
9,765
Market Cap
55.42B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.74B1.59B25.83%
Dec 31, 20246.15B970.00M18.72%
Dec 31, 20235.18B-265.00M-4.87%
Dec 31, 20225.45B-330.00M-5.71%
Dec 31, 20215.78B430.00M8.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Northwest Biotherapeutics 937.00K
Silence Therapeutics 559.00K
Vaxart 148.20M
BioStem Technologies 292.21M
Nuo Therapeutics 2.61M
Arch Biopartners 115.29K
ZIVO Bioscience 209.03K
Revenue Rankings

UCB SA News

More News